Trial · NCT04989257
24-month Ticagrelor-based Dual-antiplatelet Therapy Versus Clopidogrel-based Dual-antiplatelet theRapy aftEr 12 Months of DrUg-eluting Stent Implantation in High isChEmic Risk Patients: P-REDUCE Trial
NCT04989257, Not applicable, Unknown, Yonsei University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. 24-month Ticagrelor-based Dual-antiplatelet Therapy Versus Clopidogrel-based Dual-antiplatelet theRapy aftEr 12 Months of DrUg-eluting Stent Implantation in High isChEmic Risk Patients: P-REDUCE Trial. Trials, record NCT04989257. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04989257
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- 24-month Ticagrelor-based Dual-antiplatelet Therapy Versus Clopidogrel-based Dual-antiplatelet theRapy aftEr 12 Months of DrUg-eluting Stent Implantation in High isChEmic Risk Patients: P-REDUCE Trial
- NCT number
- NCT04989257
- Status
- Unknown
- Phases
- Not applicable
- Enrollment
- 3,488 participants, estimated
- Lead sponsor
- Yonsei University
- Conditions
- High Ischemic Risk
- Interventions
- Ticagrelor-based dual-antiplatelet therapy, Clopidogrel-based dual-antiplatelet therapy
- First posted
- 2021-08-04
- Last updated
- 2021-08-04
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Composite of all-cause death, myocardial infarction, or stroke | up to 24 months | Composite of all-cause death, myocardial infarction, or stroke at 24 months after randomization |
| Secondary | BARC type 2, 3, or 5 bleeding | up to 24 months | BARC type 2, 3, or 5 bleeding at 24 months after randomization |
| Secondary | All-cause death | up to 24 months | All-cause death at 24 months after randomization |
| Secondary | Myocardial infarction | up to 24 months | Myocardial infarction at 24 months after randomization |
| Secondary | Stroke | up to 24 months | Stroke at 24 months after randomization |
| Secondary | Cardiac death | up to 24 months | Cardiac death at 24 months after randomization |
| Secondary | Composite of all-cause death, myocardial infarction, stroke, or BARC type 2, 3, or 5 bleeding | up to 24 months | Composite of all-cause death, myocardial infarction, stroke, or BARC type 2, 3, or 5 bleeding at 24 months after randomization |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04989257
GET https://conductscience.org/api/trials/v1/NCT04989257/registered